Analysis of CFTR, SPINK1, PRSS1 and AAT mutations in children with acute or chronic pancreatitis

Journal of Pediatric Gastroenterology and Nutrition

Volumn 43, Issue 3, 2006, Pages 299-306

  Sobczyńska Tomaszewska, Agnieszka ^a   Bak, Daniel ^a,b   Oralewska, Beata ^c   Oracz, Grzegorz ^c   Norek, Aleksandra ^a,d   Czerska, Kamila ^a,b   Mazurczak, Tadeusz ^a   Teisseyre, Mikołaj ^c   Socha, Jerzy ^c   Zagulski, Marek ^e   Bal, Jerzy ^a  

^a INSTITUTE OF MOTHER AND CHILD   (Poland)

^b POSTGRADUATE SCHOOL OF MOLECULAR MEDICINE   (Poland)

^c CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^d LODZ UNIVERSITY OF TECHNOLOGY   (Poland)

^e INSTITUTE OF BIOCHEMISTRY AND BIOPHYSICS   (Poland)

Author keywords

AAT; CFTR; Pancreatitis; PRSS1; SPINK1

Indexed keywords

ALPHA 1 ANTITRYPSIN; SERINE PROTEINASE; SERINE PROTEINASE 1; SERINE PROTEINASE INHIBITOR; SERINE PROTEINASE INHIBITOR KAZA TYPE 1; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG;

ACUTE PANCREATITIS; ADOLESCENT; ADULT; ALLELE; ARTICLE; CHILD; CHRONIC PANCREATITIS; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; GENETIC DISORDER; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR GENETICS; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; RECURRENT DISEASE;

EID: 33748565320     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mpg.0000232570.48773.df     Document Type: Article

References (37)

1. Whitcomb DC, Gorry MC, Preston RA, et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet 1996;14:141-5.
2. Pho-Iam T, Thongnoppakhun W, Yenchitsomanus PT, et al. A Thai family with hereditary pancreatitis and increased cancer risk due to a mutation in PRSS1 gene. World J Gastroenterol 2005;11:1634-8.
3. Pfutzer RH, Barmada MM, Brunskill AP, et al. SPINK1/PSTI polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis. Gastroenterology 2000;119:615-23.
4. Novis BH, Young GO, Bank S, et al. Chronic pancreatitis and alpha-1-antitrypsin. Lancet 1975;2:748-9.
5. Sharer N, Schwarz M, Malone G, et al. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med 1998;339:645-52.
6. Cohn JA, Friedman KJ, Noone PG, et al. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N Engl J Med 1998;339:653-8.
7. Sarner M, Cotton PB. Definitions of acute and chronic pancreatitis. Clin Gastroenterol 1984;13:865-70.
8. Sarner M, Cotton PB. Classification of pancreatitis. Gut 1984;25:756-9.
9. Van de Kamer JH, Ten Bokkel Huinink H, Weyers HA. Rapid method for the determination of fat in feces. J Biol Chem 1949;177:347-55.
10. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
11. Witt H, Luck W, Becker M. A signal peptide cleavage site mutation in the cationic trypsinogen gene is strongly associated with chronic pancreatitis. Gastroenterology 1999;117:7-10.
12. Ferec C, Raguenes O, Salomon R, et al. Mutations in the cationic trypsinogen gene and evidence for genetic heterogeneity in hereditary pancreatitis. J Med Genet 1999;36:228-32.
13. Simon P, Weiss FU, Sahin-Toth M, et al. Hereditary pancreatitis caused by a novel PRSS1 mutation (Arg-122→Cys) that alters autoactivation and autodegradation of cationic trypsinogen. J Biol Chem 2002;277:5404-10.
14. Plendl H, Siebert R, Steinmann D, et al. High frequency of the N34S mutation in the SPINK1 gene in chronic pancreatitis detected by a new PCR-RFLP assay. Am J Med Genet 2001;100:252-3.
15. 1-antitrypsin enhancer polymorphism is a genetic modifier of pulmonary outcome in cystic fibrosis. Eur J Hum Genet 2001;9:273-8.
16. Dork T, Macek M, Mekus F, et al. A novel 21 kilobase deletion, CFTR dele2,3 (21 kb), in the CFTR gene: a cystic fibrosis mutation of Slavic origin common in Central and East Europe. Hum Genet 2000;106:259-68.
17. Chillon M, Casals T, Mercier B, et al. Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deference. N Engl J Med 1995;332:1475-80.
18. Rommens J, Kerem BS, Greer W, et al. Rapid nonradioactive detection of the major cystic fibrosis mutation. Am J Hum Genet 1990;46:395-6.
19. Comfort M, Steinberg A. Pedigree of a family with hereditary chronic relapsing pancreatitis. Gastroenterology 1952;21:54-63.
20. Audrezet MP, Chen JM, Le Marechal C, et al. Determination of the relative contribution of three genes - the cystic fibrosis transmembrane conductance regulator gene, the cationic trypsinogen gene, and the pancreatic secretory trypsin inhibitor gene - to the etiology of idiopathic chronic pancreatitis. Eur J Hum Genet 2002;10:100-6.
21. Aznarez I, Bal J, Casals T, et al. Analysis of mutations in the CFTR gene in patients diagnosed with cystic fibrosis in Poland. Med Wieku Rozwoj 2000;4:149-59.
22. Durno C, Corey M, Zielenski J, et al. Genotype and phenotype correlations in patients with cystic fibrosis and pancreatitis. Gastroenterology 2002;123:1857-64.
23. Oppenheimer EH, Esterly JR. Pathology of cystic fibrosis: review of the literature and comparison with 146 autopsied cases. Perspect Pediatr Pathol 1975;2:241-78.
24. Lempinen M, Paju A, Kemppainen E, et al. Mutations N34S and P55S of the SPINK1 gene in patients with chronic pancreatitis or pancreatic cancer and in healthy subjects: a report from Finland. Scand J Gastroenterol 2005;40:225-30.
25. Witt H, Luck W, Hennies HC, et al. Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat Genet 2000;25:213-6.
26. Witt H, Luck W, Becker M, et al. Mutation in the SPINK1 trypsin inhibitor gene, alcohol use, and chronic pancreatitis. JAMA 2001;285:2716-7.
27. Rinderknecht H. Pancreatic secretory enzymes. In: Go VLW, DiMagno EP, Gardner JD, et al, eds. The Pancreas: Biology, Pathobiology and Disease, 2nd ed. New York: Raven, 1993:219-51.
28. Sahin-Toth M, Toth M. Gain-of-function mutations associated with hereditary pancreatitis enhance autoactivation of human cationic trypsinogen. Biochem Biophys Res Commun 2000;278:286-9.
29. Kukor Z, Toth M, Pal G, et al. Human cationic trypsinogen. Arg(117) is the reactive site of an inhibitory surface loop that controls spontaneous zymogen activation. J Biol Chem 2002;277:6111-7.
30. Sibert JR. Hereditary pancreatitis in England and Wales. J Med Genet 1978;15:189-201.
31. Howes N, Lerch MM, Greenhalf W, et al. Clinical and genetic characteristics of hereditary pancreatitis in Europe. Clin Gastroenterol Hepatol 2004;2:252-61.
32. Lowenfels AB, Maisonneuve P, DiMagno EP, et al. Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group. J Natl Cancer Inst 1997;89:442-6.
33. Ulrich CD, Consensus Committees of the European Registry of Hereditary Pancreatic Diseases, Midwest Multi-Center Pancreatic Study Group, International Association of Pancreatology. Pancreatic cancer in hereditary pancreatitis: consensus guidelines for prevention, screening and treatment. Pancreatology 2001;1:416-22.
34. Braxel C, Versieck J, Lemey G, et al. Alpha 1-antitrypsin in pancreatitis. Digestion 1982;23:93-6.
35. Larsson C. Natural history and life expectancy in severe alpha1-antitrypsin deficiency, PiZ. Acta Med Scand 1978;204:345-51.
36. Teich N, Walther H, Bodeker J, et al. Relevance of variants in serum antiproteinases for the course of chronic pancreatitis. Scand J Gastroenterol 2002;3:360-5.
37. Witt H, Kage A, Luck W, et al. Alpha1-antitrypsin genotypes in patients with chronic pancreatitis. Scand J Gastroenterol 2002;37:356-9.